| 000 | 01390 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512223057.0 | ||
| 264 | 0 | _c19830923 | |
| 008 | 198309s 0 0 eng d | ||
| 022 | _a0033-5622 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavie, M W | |
| 245 | 0 | 0 |
_aLow plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D. _h[electronic resource] |
| 260 |
_bThe Quarterly journal of medicine _c1983 |
||
| 300 |
_a79-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _a25-Hydroxyvitamin D 2 |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 |
_aCalcium _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aEpilepsy _xblood |
| 650 | 0 | 4 |
_aErgocalciferols _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 |
_aVitamin D _xtherapeutic use |
| 650 | 0 | 4 |
_aVitamin D Deficiency _xchemically induced |
| 700 | 1 | _aEmberson, C E | |
| 700 | 1 | _aLawson, D E | |
| 700 | 1 | _aRoberts, G E | |
| 700 | 1 | _aBarnes, J L | |
| 700 | 1 | _aBarnes, N D | |
| 700 | 1 | _aHeeley, A F | |
| 773 | 0 |
_tThe Quarterly journal of medicine _gvol. 52 _gno. 205 _gp. 79-91 |
|
| 999 |
_c6603455 _d6603455 |
||